Dr. Olga H. Toro‑Salazar is a Professor of Pediatrics at Vanderbilt University Medical Center School of Medicine and a nationally recognized leader in pediatric cardio‑oncology and advanced cardiac imaging. A graduate of Universidad Javeriana in Bogotá, Colombia, she completed pediatric residency training at the University of Connecticut, followed by a Pediatric Cardiology fellowship at the University of Minnesota and advanced cardiac MRI training at Boston Children’s Hospital. She previously served as Chief of Pediatric Cardiology at Fundación Clínica Valle del Lili in Cali, Colombia, where she established a comprehensive regional pediatric cardiology program.
Dr. Toro‑Salazar’s unwavering commitment to health equity and global child health has shaped her career. A bilingual pediatric cardiologist, she has consistently leveraged her clinical and academic expertise to improve outcomes for children in under‑resourced communities worldwide. In 2004, she created an institutional partnership between Connecticut Children’s and the National University of Asunción in Paraguay to build sustainable pediatric cardiology capacity. Through this collaboration, she helped develop a self-sustaining program that provides early diagnosis and surgical repair for children with congenital and rheumatic heart disease, regardless of socioeconomic status. Dr. Toro‑Salazar co‑directed four Paraguayan‑American pediatric cardiac surgical missions—in 2005, 2006, 2008, and 2011—working closely with local clinicians. These efforts delivered life‑saving surgeries and established durable training pathways for Paraguayan physicians and surgeons, creating long‑term infrastructure for cardiac care.
Dr. Toro‑Salazar is a pioneer in identifying subclinical cardiotoxicity in childhood cancer survivors, utilizing cardiac MRI and myocardial strain imaging to detect early myocardial injury not captured by traditional metrics. Her work has informed modern surveillance strategies, contributed to national guidelines—including the American Society of Echocardiography’s 2023 recommendations—and supported cost‑effective screening approaches for centers without MRI access. She has authored 25 peer‑reviewed publications and serves as an investigator in multiple multicenter research collaborations.
As Director of Non‑Invasive Cardiac Imaging at Connecticut Children’s, she developed one of the region’s leading congenital and cardio‑oncology imaging programs. She is also a dedicated educator who teaches across all stages of medical training and has earned multiple awards for clinical teaching and mentorship. Her guidance has enabled residents and fellows to secure competitive grant funding and pursue successful careers in pediatric cardiology.
At Vanderbilt, Dr. Toro‑Salazar leads Pediatric Cardio‑Oncology and Dimensional Cardiac Imaging, spearheading the strategic development, clinical integration, and research advancement of cardiovascular imaging and survivorship care in cardio‑oncology. Building on her prior experience, she is establishing a comprehensive precision cardio‑oncology program that integrates advanced imaging, genomics, and clinical data analytics to deliver personalized care for individuals at risk for—or experiencing—cardiotoxicity. This initiative is designed to drive innovation, enhance early detection, improve risk stratification, and optimize management strategies for treatment‑related cardiac dysfunction.
